---
pmid: '20823234'
title: Notch signaling contributes to proliferation and tumor formation of human T-cell
  leukemia virus type 1-associated adult T-cell leukemia.
authors:
- Pancewicz J
- Taylor JM
- Datta A
- Baydoun HH
- Waldmann TA
- Hermine O
- Nicot C
journal: Proc Natl Acad Sci U S A
year: '2010'
full_text_available: false
pmcid: PMC2944748
doi: 10.1073/pnas.1010722107
---

# Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia.
**Authors:** Pancewicz J, Taylor JM, Datta A, Baydoun HH, Waldmann TA, Hermine O, Nicot C
**Journal:** Proc Natl Acad Sci U S A (2010)
**DOI:** [10.1073/pnas.1010722107](https://doi.org/10.1073/pnas.1010722107)
**PMC:** [PMC2944748](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944748/)

## Abstract

1. Proc Natl Acad Sci U S A. 2010 Sep 21;107(38):16619-24. doi: 
10.1073/pnas.1010722107. Epub 2010 Sep 7.

Notch signaling contributes to proliferation and tumor formation of human T-cell 
leukemia virus type 1-associated adult T-cell leukemia.

Pancewicz J(1), Taylor JM, Datta A, Baydoun HH, Waldmann TA, Hermine O, Nicot C.

Author information:
(1)Department of Pathology, University of Kansas Medical Center, Kansas City, KS 
66160, USA.

The Notch signaling pathway plays an important role in cellular proliferation, 
differentiation, and apoptosis. Unregulated activation of Notch signaling can 
result in excessive cellular proliferation and cancer. Human T-cell leukemia 
virus type 1 (HTLV-I) is the etiological agent of adult T-cell leukemia (ATL). 
The disease has a dismal prognosis and is invariably fatal. In this study, we 
report a high frequency of constitutively activated Notch in ATL patients. We 
found activating mutations in Notch in more than 30% of ATL patients. These 
activating mutations are phenotypically different from those previously reported 
in T-ALL leukemias and may represent polymorphisms for activated Notch in human 
cancers. Compared with the exclusive activating frameshift mutations in the 
proline, glutamic acid, serine, and threonine (PEST) domain in T-ALLs, those in 
ATLs have, in addition, single-substitution mutations in this domain leading to 
reduced CDC4/Fbw7-mediated degradation and stabilization of the intracellular 
cleaved form of Notch1 (ICN1). Finally, we demonstrated that inhibition of Notch 
signaling by Î³-secretase inhibitors reduced tumor cell proliferation and tumor 
formation in ATL-engrafted mice. These data suggest that activated Notch may be 
important to ATL pathogenesis and reveal Notch1 as a target for therapeutic 
intervention in ATL patients.

DOI: 10.1073/pnas.1010722107
PMCID: PMC2944748
PMID: 20823234 [Indexed for MEDLINE]

Conflict of interest statement: The authors declare no conflict of interest.
